Dollar cost averaging (DCA) in KALV means investing a fixed amount at regular intervals, regardless of share price. This strategy reduces timing risk and builds wealth steadily through market ups and downs.
How This Calculator Works
Our DCA calculator simulates real market conditions using historical price data. It accounts for dividend reinvestment (DRIP), where each dividend payment automatically purchases additional shares. You can adjust the investment amount, frequency, time period, and compare against benchmarks like the S&P 500 and Nasdaq-100.
More KALV Analysis
KALV DCA Calculator
Dollar Cost Averaging — KalVista Pharmaceuticals, Inc.
Same amount invested each month — only the day of purchase changes. How much does intra-month timing actually matter?
Best Timing DCA
StrategyBuy on monthly low
Total Return+132.7%
Final Value$111.7K
Perfectly timed — impossible in practice
Your DCA
StrategyBuy on 1st of month
Total Return+106.6%
Final Value$99.2K
Consistent — no timing needed
Worst Timing DCA
StrategyBuy on monthly high
Total Return+86.8%
Final Value$89.7K
Worst possible — still beats not investing
Best vs Worst gap45.9 pp
Your timing vs best-26.1%
Your timing vs worst+19.8%
If You Keep Investing…
Based on this stock's historical CAGR of 12.1%/yr — put in vs. walk away with.
Your Plan
At $500/mo, this could grow into:
3 Years$21K~1.2x your moneyfrom $18K invested
5 Years$40K~1.3x your moneyfrom $30K invested
10 Years$112K~1.9x your moneyfrom $60K invested
20 Years$463K~3.9x your moneyfrom $120K invested
Compare Other Monthly Amounts
Same CAGR assumption. Use this to pressure-test different monthly commitments.
Monthly
3 Years~1.2x your money
5 Years~1.3x your money
10 Years~1.9x your money
20 Years~3.9x your money
$100/mo
$4K+$675 est. gain
$8K+$2K est. gain
$22K+$10K est. gain
$93K+$69K est. gain
$250/mo
$11K+$2K est. gain
$20K+$5K est. gain
$56K+$26K est. gain
$231K+$171K est. gain
$500/mo
$21K+$3K est. gain
$40K+$10K est. gain
$112K+$52K est. gain
$463K+$343K est. gain
$1,000/mo
$43K+$7K est. gain
$81K+$21K est. gain
$223K+$103K est. gain
$925K+$685K est. gain
* Projection assumes historical CAGR of 12.1% continues. Actual returns will vary.
Your DCA Results by Date
77 purchases
Date
Price
Invested
Portfolio Value
% Gain
Gain ($)
Jan 2, 2020
$18.08
$10,000
$10,000
+0.00%
$0
Feb 3, 2020
$15.89
$10,500
$9,289
-11.54%
$-1,211
Mar 2, 2020
$14.33
$11,000
$8,877
-19.30%
$-2,123
Apr 2, 2020
$7.43
$11,500
$5,103
-55.63%
$-6,397
May 4, 2020
$10.93
$12,000
$8,006
-33.28%
$-3,994
Jun 2, 2020
$11.09
$12,500
$8,623
-31.01%
$-3,877
Jul 2, 2020
$12.97
$13,000
$10,585
-18.58%
$-2,415
Aug 3, 2020
$10.94
$13,500
$9,428
-30.16%
$-4,072
Sep 2, 2020
$12.73
$14,000
$11,471
-18.06%
$-2,529
Oct 2, 2020
$12.97
$14,500
$12,187
-15.95%
$-2,313
Nov 2, 2020
$16.86
$15,000
$16,343
+8.95%
$1,343
Dec 2, 2020
$18.43
$15,500
$18,365
+18.48%
$2,865
Jan 4, 2021
$18.08
$16,000
$18,516
+15.72%
$2,516
Feb 2, 2021
$15.12
$16,500
$15,984
-3.12%
$-516
Mar 2, 2021
$32.34
$17,000
$34,689
+104.05%
$17,689
Apr 5, 2021
$28.10
$17,500
$30,641
+75.09%
$13,141
May 3, 2021
$24.96
$18,000
$27,717
+53.98%
$9,717
Jun 2, 2021
$26.64
$18,500
$30,083
+62.61%
$11,583
Jul 2, 2021
$23.44
$19,000
$26,969
+41.94%
$7,969
Aug 2, 2021
$20.45
$19,500
$24,029
+23.23%
$4,529
Sep 2, 2021
$20.88
$20,000
$25,034
+25.17%
$5,034
Oct 4, 2021
$17.15
$20,500
$21,062
+2.74%
$562
Nov 2, 2021
$18.09
$21,000
$22,717
+8.17%
$1,717
Dec 2, 2021
$13.45
$21,500
$17,390
-19.12%
$-4,110
Jan 3, 2022
$13.91
$22,000
$18,485
-15.98%
$-3,515
Page 1 of 4
Frequently Asked Questions
Common questions about DCA investing in KALV
Investing $500 per month in KalVista Pharmaceuticals, Inc. (KALV) over the past 6 years would be worth approximately $99K today. That's +106.6% total return on $48K invested, with a +12.1% compound annual growth rate (CAGR).